HealthVerity, Inc., a Philadelphia, PA-based company focused on the rapid creation, exchange and management of healthcare and consumer data, closed a $25m Series C funding.
The round was led by existing investor Foresite Capital with participation from Flare Capital Partners, Greycroft Partners and other existing investors.
The company intends to use the new capital for continued growth and investment in its technology platform and go-to-market activities.
Led by Andrew Kress, co-founder and CEO, HealthVerity provides:
– Census, a SaaS solution for activating, de-identifying and linking data across the enterprise and beyond,
– Marketplace, a cloud platform for discovery and licensing of broad scale healthcare and consumer data in a privacy-protecting manner, and
– Consent, a blockchain-driven platform for managing patient and consumer permissions in an immutable and auditable manner.
The company serves customers including more than 100 of the top Pharmaceutical Manufacturers, Health Insurance Payers, Pharmaceutical Services firms and Healthcare Services organizations.